文献速递前列腺癌

非学术机构早期前列腺癌主动监测的中期随访

Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution.
PubMed 文献 · BJU Int · 2024-01-22

该研究报告了单一非学术机构采用标准化PRIAS方案开展主动监测(AS)的肿瘤学结局,纳入2010至2022年间341例Grade Group 1前列腺癌(PCa)男性。随访期间无PCa死亡,2例发生远处转移且研究结束时存活;10年累积转移发生率为1.9%(95%CI 0.33-6.4%)。未满足至少一项PRIAS纳入标准者(n=43)的重分类发生率更高(亚分布风险比1.73,95%CI 1.07-2.81;P=0.03),但根治性前列腺切除术后不良病理发现率相似。

要点

  • 非学术机构采用PRIAS方案行AS,10年累积转移发生率为1.9%(95%CI 0.33-6.4%)。
  • 未满足至少一项PRIAS纳入标准者重分类风险更高(亚分布风险比1.73;P=0.03)。
  • 两组根治性前列腺切除术后不良病理发现率相似。

核心结论

  • 非学术机构AS男性的转移发生率与国际成熟队列报告的一样低。
  • 未严格按纳入标准随访的男性应被告知重分类发生率更高,并可放心其不良病理发现率与满足全部标准者相当。
  • 因此,无论随访在学术机构还是较小社区医院进行,低级别PCa男性均应接受AS。

研究设计与样本

  • 单中心非学术机构采用标准化PRIAS方案开展AS的肿瘤学结局报告。
  • 采用竞争风险分析估计总体死亡、转移、转为治疗和分级重分类的发生率。
  • 比较满足全部PRIAS纳入标准者与未满足至少一项者之间重分类及根治性前列腺切除术后不良病理发现的发生率。
  • 分析2010至2022年间341例Grade Group 1前列腺癌男性。

主要发现

  • 无PCa死亡,2例发生远处转移且研究结束时存活。
  • 10年累积转移发生率为1.9%(95%CI 0.33-6.4%)。
  • 111例发生重分类,127例接受确定性治疗。
  • 未满足至少一项PRIAS纳入标准者(n=43)重分类发生率更高(亚分布风险比1.73,95%CI 1.07-2.81;P=0.03)。
  • 未满足至少一项PRIAS纳入标准者与满足全部标准者根治性前列腺切除术后不良病理发现率相似。

关键数值与推荐

  • 10年累积转移发生率1.9%(95%CI 0.33-6.4%)。
  • 未满足至少一项PRIAS纳入标准者重分类的亚分布风险比1.73(95%CI 1.07-2.81;P=0.03)。

临床怎么用

  • 作者认为,无论随访在学术机构还是较小社区医院进行,低级别PCa男性均应接受AS。
  • 作者认为,未严格按纳入标准随访的男性应被告知重分类发生率更高,并可放心其不良病理发现率与满足全部标准者相当。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To report oncological outcomes of active surveillance (AS) at a single non-academic institution adopting the standardised Prostate Cancer Research International Active Surveillance (PRIAS) protocol. PATIENTS AND METHODS: Competing risk analyses estimated the incidence of overall mortality, metastases, conversion to treatment, and grade reclassification. The incidence of reclassification and adverse pathological findings at radical prostatectomy were compared between patients fulfilling all PRIAS inclusion criteria vs those not fulfilling at least one. RESULTS: We analysed 341 men with Grade Group 1 prostate cancer (PCa) followed on AS between 2010 and 2022. There were no PCa deaths, two patients developed distant metastases and were alive at the end of the study period. The 10-year cumulative incidence of metastases was 1.9% (95% confidence interval [CI] 0.33-6.4%). A total of 111 men were reclassified, and 127 underwent definitive treatment. Men not fulfilling at least one PRIAS inclusion criteria (n = 43) had a higher incidence of reclassification (subdistribution hazards ratio 1.73, 95% CI 1.07-2.81; P = 0.03), but similar rates of adverse pathological findings at radical prostatectomy. CONCLUSION: Metastases in men on AS at a non-academic institution are as rare as those reported in established international cohorts. Men followed without stringent inclusion criteria should be counselled about the higher incidence of reclassification and reassured they can expect rates of adverse pathological findings comparable to those fulfilling all criteria. Therefore, AS should be proposed to all men with low-grade PCa regardless of whether they are followed at academic institutions or smaller community hospitals.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Leni R, Roscigno M, Barzaghi P, et al. Medium-term follow up of active surveillance for early prostate cancer at a non-academic institution. BJU Int. 2024. PMID: 38093673. doi:10.1111/bju.16259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。